Kardashian Barker discusses the brand’s latest hair growth and anti-shedding capsule launch, her current post-pregnancy hair ...

KOURTNEY Kardashian is facing backlash after being branded “shameless” over an ill-timed birthday post on Kris Jenner’s birthday. Reality star Kourtney, 45, came under fire for ...

Lemme’s new supplement is named GLP-1 Daily - a direct reference to the Ozempic hormone. It is designed to “reduce body weight, visceral fat, and hip and waist circumference”, according to ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Advertisement Under the Medicaid system ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under the Medicaid system, individual states ...

Hims & Hers Health (NYSE:HIMS) is gearing up to launch an off-patent version of Novo Nordisk's (NVO) (OTCPK:NONOF) older GLP-1 weight loss therapy liraglutide in 2025, CEO of the telehealth ...

The survey of 1,000 participants between the ages of 21-75, found that more than three-quarters (78%) of consumers discussed lifestyle changes before receiving or when receiving a GLP-1 ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams. (HealthDay News) — In a multisociety clinical practice guidance ...

Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity. (HealthDay News) — From 2010 to 2023, there was an ...